Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension

NCT05920005 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

702

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: candesartan cilexetil + chlorthalidone + amlodipine
DRUG: Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)

Sponsor

Hospital Israelita Albert Einstein

Collaborators

[object Object]